Table 2.
Comparison of the clinical and pathological characteristics between the well-controlled and poorly controlled groups
|
Variables
|
Well-controlled group (n = 73)
|
Poorly controlled group (n = 45)
|
P value
|
| Age (year, mean ± SD) | 62.55 ± 8.59 | 62.93 ± 7.55 | 0.805 |
| Gender (male/female) | 35/38 | 25/20 | 0.422 |
| BMI > 24 kg/m2 (present/absent) | 20/53 | 16/29 | 0.350 |
| History of smoke (present/absent) | 31/42 | 24/21 | 0.250 |
| History of drinking (present/absent) | 29/44 | 22/23 | 0.329 |
| Hypertension (present/absent) | 25/48 | 13/32 | 0.545 |
| Cardiovascular disease (present/absent) | 14/59 | 10/35 | 0.690 |
| HbA1c (%, mean ± SD) | 5.93 ± 0.56 | 7.60 ± 1.13 | < 0.001a |
| FPG (mmol/L, mean ± SD) | 6.49 ± 1.91 | 8.55 ± 3.75 | 0.001a |
| CEA (ng/mL, mean ± SD) | 31.27 ± 118.37 | 87.98 ± 240.80 | 0.146 |
| CA19-9 (ng/mL, mean ± SD) | 28.38 ± 88.07 | 265.26 ± 1486.75 | 0.291 |
| T stage (3/4) | 51/22 | 31/14 | 0.911 |
| N stage (1/2) | 48/25 | 28/17 | 0.697 |
| Tumor location (RCC/LCC) | 29/44 | 20/25 | 0.613 |
| Tumor size (cm, mean ± SD) | 4.63 ± 1.95 | 4.73 ± 1.89 | 0.772 |
| Vascular invasion (present/absent) | 21/52 | 10/35 | 0.433 |
| Perineural invasion (present/absent) | 23/50 | 17/28 | 0.485 |
| Tumor differentiation (MD/PD) | 56/17 | 39/6 | 0.185 |
a
P < 0.05.
BMI: Body mass index; HbA1c: Glycosylated hemoglobin; FPG: Fasting plasma glucose; CEA: Carcinoembryonic antigen; CA19-9: Carbohydrate antigen 199; LCC: Left-side colon cancer; RCC: Right-side colon cancer; MD: Moderately differentiated; PD: Poorly differentiated.